iwCLL

1-888-476-9129 info@bioascend.com

Menu
2017 Presentations

IL-4R – IL-4 axis Disruption by Ibrutinib Therapy Contributes to the Greater Vulnerability of U-CLL Clones to Loss of Microenvironmental Inputs


Shih-Shih Chen